PLA2G7 and diabetic retinopathy: It has been confirmed that Lp-PLA2 and its main enzyme product lysoPC can participate in diabetic retinopathy by disrupting the blood retinal barrier (BRB) (Canning et al., 2016; Acharya et al., 2017).